Timeline — Health Updates

Under the Clinical Establishment Rules, laboratories are divided into three categories - basic composite, medium and advanced. The standards prescribe the scope of services, infrastructure, equipment, human resources, record maintenance and other operational requirements for each category.

Under the Clinical Establishment Rules, laboratories are divided into three categories - basic composite, medium and advanced. The standards prescribe the scope of services, infrastructure, equipment, human resources, record maintenance and other operational requirements for each category.

Under the Clinical Establishment Rules, laboratories are divided into three categories - basic composite, medium and advanced. The standards prescribe the scope of services, infrastructure, equipment, human resources, record maintenance and other operational requirements for each category.

Under the Clinical Establishment Rules, laboratories are divided into three categories - basic composite, medium and advanced. The standards prescribe the scope of services, infrastructure, equipment, human resources, record maintenance and other operational requirements for each category.

In the study published in Nature Immunology, researchers found the antibodies were present in higher levels and appeared earlier in pregnancy in women who went on to give birth before 37 weeks' gestation compared to those who delivered their babies at term.

In the study published in Nature Immunology, researchers found the antibodies were present in higher levels and appeared earlier in pregnancy in women who went on to give birth before 37 weeks' gestation compared to those who delivered their babies at term.

In the study published in Nature Immunology, researchers found the antibodies were present in higher levels and appeared earlier in pregnancy in women who went on to give birth before 37 weeks' gestation compared to those who delivered their babies at term.

In the study published in Nature Immunology, researchers found the antibodies were present in higher levels and appeared earlier in pregnancy in women who went on to give birth before 37 weeks' gestation compared to those who delivered their babies at term.

FSSAI flagged Nestle's claim that "5 HMOs helps support normal immune system", saying it could imply that the product was suitable for supporting immunity in relation to a specific physiological condition.

FSSAI flagged Nestle's claim that "5 HMOs helps support normal immune system", saying it could imply that the product was suitable for supporting immunity in relation to a specific physiological condition.

FSSAI flagged Nestle's claim that "5 HMOs helps support normal immune system", saying it could imply that the product was suitable for supporting immunity in relation to a specific physiological condition.

FSSAI flagged Nestle's claim that "5 HMOs helps support normal immune system", saying it could imply that the product was suitable for supporting immunity in relation to a specific physiological condition.

GLP-1 drugs like Novo Nordisk's Ozempic and Wegovy rank among the biggest medical breakthroughs in years, owing to their efficacy in treating obesity and type 2 diabetes, and reducing the risk of heart disease. Some 10 million Americans used them last year, a figure that could grow to 25 million by 2030, according to JPMorgan research.

GLP-1 drugs like Novo Nordisk's Ozempic and Wegovy rank among the biggest medical breakthroughs in years, owing to their efficacy in treating obesity and type 2 diabetes, and reducing the risk of heart disease. Some 10 million Americans used them last year, a figure that could grow to 25 million by 2030, according to JPMorgan research.

GLP-1 drugs like Novo Nordisk's Ozempic and Wegovy rank among the biggest medical breakthroughs in years, owing to their efficacy in treating obesity and type 2 diabetes, and reducing the risk of heart disease. Some 10 million Americans used them last year, a figure that could grow to 25 million by 2030, according to JPMorgan research.

GLP-1 drugs like Novo Nordisk's Ozempic and Wegovy rank among the biggest medical breakthroughs in years, owing to their efficacy in treating obesity and type 2 diabetes, and reducing the risk of heart disease. Some 10 million Americans used them last year, a figure that could grow to 25 million by 2030, according to JPMorgan research.

Non-communicable diseases account for three-quarters of deaths worldwide but affect different population groups in different ways, a World Health Organization study showed on Tuesday. In its biggest-ever look at inequality in health and non-communicable diseases (NCDs), the WHO studied the top four killers -- cancer, cardiovascular diseases, chronic respiratory diseases and diabetes.

According to circulars uploaded on exchanges' websites, Paras Healthcare has allotted 94,15,584 equity shares to 39 funds at Rs 693 apiece, aggregating to Rs 652.5 crore.

In a social media post on Monday, the Food and Safety and Standards Authority of India (FSSAI) has issued an advisory on 'mandatory compliance with labelling requirements and warning statements for plant and botanical ingredients and their extracts'.

In a social media post on Monday, the Food and Safety and Standards Authority of India (FSSAI) has issued an advisory on 'mandatory compliance with labelling requirements and warning statements for plant and botanical ingredients and their extracts'.